MX2023014809A - Metodos de purificacion por columna de vectores aav. - Google Patents

Metodos de purificacion por columna de vectores aav.

Info

Publication number
MX2023014809A
MX2023014809A MX2023014809A MX2023014809A MX2023014809A MX 2023014809 A MX2023014809 A MX 2023014809A MX 2023014809 A MX2023014809 A MX 2023014809A MX 2023014809 A MX2023014809 A MX 2023014809A MX 2023014809 A MX2023014809 A MX 2023014809A
Authority
MX
Mexico
Prior art keywords
purification methods
aav vector
column purification
vector column
full
Prior art date
Application number
MX2023014809A
Other languages
English (en)
Spanish (es)
Inventor
Mi Jin
Ohnmar Khanal
Vijesh Kumar
Original Assignee
Spark Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spark Therapeutics Inc filed Critical Spark Therapeutics Inc
Publication of MX2023014809A publication Critical patent/MX2023014809A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/422—Displacement mode
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
MX2023014809A 2021-06-11 2022-06-10 Metodos de purificacion por columna de vectores aav. MX2023014809A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163209680P 2021-06-11 2021-06-11
US202263366094P 2022-06-09 2022-06-09
PCT/US2022/072859 WO2022261663A1 (en) 2021-06-11 2022-06-10 Aav vector column purification methods

Publications (1)

Publication Number Publication Date
MX2023014809A true MX2023014809A (es) 2024-01-29

Family

ID=84426294

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023014809A MX2023014809A (es) 2021-06-11 2022-06-10 Metodos de purificacion por columna de vectores aav.

Country Status (13)

Country Link
US (1) US20240271159A1 (cg-RX-API-DMAC7.html)
EP (1) EP4351755A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024525142A (cg-RX-API-DMAC7.html)
KR (1) KR20240021231A (cg-RX-API-DMAC7.html)
AU (1) AU2022289035A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023025999A2 (cg-RX-API-DMAC7.html)
CA (1) CA3221540A1 (cg-RX-API-DMAC7.html)
CL (2) CL2023003646A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023018191A2 (cg-RX-API-DMAC7.html)
IL (1) IL309070A (cg-RX-API-DMAC7.html)
MX (1) MX2023014809A (cg-RX-API-DMAC7.html)
PE (1) PE20240359A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022261663A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025528182A (ja) * 2022-08-12 2025-08-26 ウルトラジェニックス ファーマシューティカル インコーポレイテッド 完全な組換えアデノ関連性ウイルス粒子から空の粒子を分離するための新規な陰イオン交換クロマトグラフィーの方法
EP4670812A1 (en) * 2024-06-27 2025-12-31 Sartorius Stedim Biotech GmbH CONTINUOUS POLISHING OF VIRAL CAPSIDES
US20260085295A1 (en) * 2024-09-23 2026-03-26 Regeneron Pharmaceuticals, Inc. PARTITIONING ANION EXCHANGE CHROMATOGRAPHY FOR PURIFICATION OF RECOMBINANT ADENO-ASSOCIATED VIRUS (rAAV)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4559429B2 (ja) * 2003-05-21 2010-10-06 ジェンザイム・コーポレーション 空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法
AU2010227419A1 (en) * 2009-03-27 2011-10-20 Proyecto De Biomedicina Cima, S.L. Methods and compositions for the treatment of cirrhosis and liver fibrosis
EP3054006A1 (en) * 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
EP3658250A4 (en) * 2017-06-30 2021-10-27 Spark Therapeutics, Inc. AAV VECTOR COLUMN CLEANING PROCEDURE
WO2023077085A2 (en) * 2021-10-29 2023-05-04 Oxford Biomedica Solutions Llc Methods and compositions for the purification of adeno-associated virus
JP2025535118A (ja) * 2022-10-11 2025-10-22 メイラグティーエックス ユーケー アイアイ リミティド Aavカプシドの精製のためのクロマトグラフィー方法

Also Published As

Publication number Publication date
US20240271159A1 (en) 2024-08-15
PE20240359A1 (es) 2024-02-27
CA3221540A1 (en) 2022-12-15
JP2024525142A (ja) 2024-07-10
BR112023025999A2 (pt) 2024-02-27
AU2022289035A1 (en) 2024-01-04
IL309070A (en) 2024-02-01
KR20240021231A (ko) 2024-02-16
EP4351755A1 (en) 2024-04-17
EP4351755A4 (en) 2025-04-23
WO2022261663A1 (en) 2022-12-15
CO2023018191A2 (es) 2024-01-25
CL2023003646A1 (es) 2024-10-25
CL2026000535A1 (es) 2026-06-12

Similar Documents

Publication Publication Date Title
CL2023003646A1 (es) Métodos de purificación de columnas de vectores aav.
MX2020006884A (es) Metodos de purificacion de virus adenoasociado.
WO2019241535A3 (en) Anion exchange chromatography for recombinant aav production
TN2020000187A1 (en) Hybrid recombinant adeno-associated virus serotype between aav9 and aavrh74 with reduced liver tropism
MY209273A (en) Gene therapy for limb-girdle muscular dystrophy type 2c
MX2024009660A (es) Variantes de capside de aav y usos de las mismas.
EP4234688A3 (en) Adeno-associated virus purification methods
EA202190512A1 (ru) Композиции и способы для производства векторов для генной терапии
WO2018204803A8 (en) Compositions and methods of treating huntington's disease
WO2022098699A8 (en) Compositions and methods for the treatment of tauopathy
PH12021550794A1 (en) Generation of improved human pah for treatment of severe pku by liver-directed gene replacement therapy
WO2022026632A3 (en) Improved aav-mediated x-linked retinoschisis therapies
SG142330A1 (en) Anti-cd38 human antibodies and uses therefor
WO2023004407A3 (en) Adeno-associated virus compositions and methods of use thereof
UA106079C2 (uk) Індукуючі апоптоз засоби для лікування злоякісної пухлини і імунних і аутоімунних захворювань
AU2018261769A1 (en) Compositions and methods for expressing Otoferlin
WO2021226267A3 (en) Cross-species compatible adeno-associated virus compositions and methods of use thereof
EP2277996A3 (en) Methods for producing preparations of recombinant AAV virions substantially free of empty capsids
MX2025008949A (es) Arni variante
ZA202003416B (en) Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies
WO2022226289A3 (en) Aavrh74 vectors for gene therapy of muscular dystrophies
MX2025006782A (es) Degradadores de la cinasa 4 asociada al receptor de interleucina-1 (irak4) y usos de los mismos
WO2023114897A3 (en) Methods and compositions for the production of adeno-associated virus
WO2020221937A8 (en) Immunogen for preventing or treating familial frontotemporal dementia (ftd) and/or amyotrophic lateral sclerosis (als)
MX2023007612A (es) Metodos para purificacion de vectores aav por cromatografia de afinidad.